Esperion Therapeutics, Inc. 4
4 · Esperion Therapeutics, Inc. · Filed Jan 6, 2015
Insider Transaction Report
Form 4
Lalwani Narendra D.
Chief Operating Officer
Transactions
- Award
Stock Option (right to buy)
2015-01-02+50,000→ 50,000 totalExercise: $41.23Exp: 2025-01-02→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]25% of option vests on January 2, 2016 and the remainder shall vest in equal quarterly installments over a three (3) year period thereafter.